Twist Bioscience stock drops 2.35% as stable RNA-DNA interface research gains attention, Twist Bioscience reports

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience down 2.35% today

Highlights

TWST is consolidating below near-term resistance, with short-term selling pressure but maintaining a firmly bullish medium- and long-term technical setup.
Momentum signals are mixed: MACD and ADX point to buyer strength while oversold stochastic RSI and CCI flag potential for a near-term bounce.
Expected trading range for the coming week is $86.00 to $96.00, with major support near $79.75 and resistance at $93.48 to $94.40.

Twist Bioscience thanked the authors for choosing Twist Genes to support the study. A link to the published paper and article was provided.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Short-term bearish tilt as resistance holds above multi-month support

TWST is currently trading at $90.27, which is below both its MA-20 ($94.40) and the Ichimoku Kijun level ($93.48), but remains above the MA-50 ($79.75) and significantly above its MA-200 ($51.15). This configuration signals short-term pressure from sellers while the medium- and long-term structure stays bullish, and the Kijun at $93.48 is acting as immediate resistance. Near-term support is outlined by the MA-50 ($79.75), with key support at MA-100 ($65.85). Immediate resistance is found at the Ichimoku Kijun ($93.48), with key resistance at the MA-20 ($94.40).

Mixed upside momentum as sellers spark weekly pullback amid volatility

Momentum indicators on D1 are mixed: the MACD shows a strong bullish bias, while the ADX remains firm and supports ongoing buyer strength, but the HMA and CCI flag near-term weakness. RSI is neutral bullish at 51.39 and Stoch RSI is oversold, suggesting the potential for a relief bounce. BBP implies recent buyer dominance but now indicates overbought conditions, hinting at possible short-term profit-taking. Awesome Oscillator readings are inconclusive. TWST is trading flat for the week, unchanged from the previous weekly close at $90.27, and is positioned in the middle of its weekly price range. Weekly volatility stands at 14.38%, reflecting strong price swings, and current action suggests consolidation near mid-range. In today's session, the stock retreated 2.35%, marking a notable pullback from its session highs.

High upside probability as consolidation tests range boundaries

Looking ahead, the expected price range for the coming week is $86.00 to $96.00, which keeps the forecast within a realistic ±11% of the current price and well above the 52-week low ($23.30) but below the 52-week high ($105.41). Based on W1 signals (all showing Buy for RSI, ADX, MACD, and MA-50), the probability of a price increase is very high (more than 80%), while the chance of a decline is low. The baseline scenario is for sideways trading as the stock holds between MA-50 and the Kijun resistance. The bullish scenario sees a push above $93.48–$94.40, potentially triggering momentum toward upper targets near $96.00. A bearish scenario could play out if short-term support at $79.75 fails, opening downside toward $75.00. Anchored to the broader uptrend, TWST remains in the upper third of its 52-week range, with technicals pointing to consolidation before renewed directional movement.

Previously it was reported that Twist Bioscience maintained a strong bullish trend supported by robust momentum, with investors closely monitoring for a breakout or reversal. This article builds on that outlook, emphasizing that the next decisive move hinges on a confirmed breach of resistance or a loss of key support, making these levels critical for traders to watch in the short term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.